Krishnan Suma sold KRYS
March 4, 2026 · Form 4 insider transaction
Krishnan Suma sold 589 shares of Krystal Biotech, Inc. at $258.54 per share, a transaction worth $152.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
589
Price
$258.54
Total value
$152.3K
InsiderKrishnan Suma
Role—
CompanyKrystal Biotech, Inc. (KRYS)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after1,427,159
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction was executed in multiple trades ranging from $257.93 to $258.92. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.